[Hypermineralcorticism caused by topical preparation containing 9-alpha-fluoroprednisolone].
Zamora Martínez
E
E
Martín Moreno
L
L
de Castro Torres
A
A
D000328:Adult; D007644:Darier Disease / Q000188:drug therapy*; D005477:Fluprednisolone / Q000009:adverse effects* / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D014883:Water-Electrolyte Imbalance / Q000139:chemically induced*
C010958:9-fluoroprednisolone; D005477:Fluprednisolone
Hipermineralocorticismo por preparado tópico conteniendo 9-alfa-fluorprednisolona.